SSSW obtained two medical device registration certificates
SSSW recently obtained two medical device registration certificates issued by the National Medical Products Administration, including an adenovirus antigen detection kit and seven nucleic acid detection kits for respiratory pathogens. The acquisition of these registration certificates will enrich the company's product variety, enhance its competitiveness in the in vitro diagnostic field, and help improve its market expansion capabilities
According to the Zhitong Finance APP, SSSW (688399.SH) announced that the company recently received a medical device registration certificate (in vitro diagnostic reagents) issued by the National Medical Products Administration. The product names are: Adenovirus Antigen Detection Kit (Colloidal Gold Method) and Seven Respiratory Pathogen Nucleic Acid Detection Kits (Fluorescent PCR Method).
The acquisition of the above-mentioned "Medical Device Registration Certificate" enriches the company's product variety, expands the company's layout in the field of in vitro diagnostics, continuously meets diverse clinical needs, enhances the company's overall competitiveness, and is beneficial for further improving the company's market expansion capabilities
